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The feasibility of anaerobic co-digestion of pharmaceutical waste fermentation broth
(spent mycelia) mixed with pig slurry and corn-grass silage was studied. The waste broth
proved very toxic to luminescent bacteria Vibrio fischeri (30 min EC50 = 1.19–3.35 vol. %)
while it expressed lower toxicity to activated sludge (180 min EC50 = 4.11–15.32 vol. %).
Initially, stabilization studies in aerobic and anaerobic conditions were performed
to confirm feasibility of anaerobic degradation. A 30 L conventional mesophilic reactor
was used for further digestion experiments. The control experiment (pig slurry and
corn-grass silage only) with OLR of 1.5 kg m–3 d–1 achieved 70 % COD removal
and methane production of 25.4 L d–1. The first experiment with added fermentation
broth (OLR of 1.8 kg m–3 d–1) achieved 79 % COD removal and good methane pro-
duction (30.9 L d–1). The second experiment with more fermentation broth (OLR of
2.2 kg m–3 d–1) failed after 20 days, but the system recovered when the OLR was re-
duced to 2.0 kg m–3 d–1. In the third experiment only pharmaceutical broth was used as a
substrate. The process failed after 10 days of operation due to toxic shock. It has been
concluded that the toxic impact could be avoided with an OLR not higher than
2.0 kg m–3 d–1, but at the same time pharmaceutical broth must not contribute more than
25 % to the total OLR.
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Introduction
The pharmaceutical industry produces a wide
range of products, which are used in human and
veterinary medicine. All pharmaceutical manufac-
turing processes may produce considerable amounts
of wastewaters and wastes; however fermentation
and synthesis usually generate the largest volumes
of waste with high organic load.1 The anaerobic
process is very suitable for the treatment of such
high strength wastewaters and broths. Preliminary
research papers2 have already shown that pharma-
ceutical wastes mostly exhibit toxic effects to aero-
bic as well as anaerobic processes, but anaerobic
process can be adapted to a certain level of toxicity.
When properly conducted, the anaerobic process
can produce considerable amounts of biogas, con-
tributing to of the increase in renewable energy thus
reducing the environmental impacts of pharmaceu-
tical wastes with beneficial energy production. Re-
cently, many studies have shown that anaerobic
treatment of pharmaceutical wastewaters can be
successfully accomplished,3,4,5 although research
on anaerobic treatment of high strength pharma-
ceutical wastes, such as broth in our study, is
scarce. However, the pharmaceuticals remaining
in the wastewaters after separation procedures
and introduced as influent to anaerobic treatment
plant, are toxic to bacteria and therefore may sig-
nificantly decrease the efficiency of COD re-
moval and biogas production.6,7,8 Therefore, we
can assume that a similar effect may appear con-
ducting anaerobic digestion of waste pharmaceuti-
cal broth.
The aim of our research was to determine the
feasibility of co-digestion of waste pharmaceutical
broth with conventional substrates such as pig
slurry and silage in a pilot plant reactor to be later
used in a full-scale device in a local biogas produc-
tion plant currently under construction. Our goal
was to determine the properties of waste pharma-
ceutical fermentation broth, to define the conditions
of the digestion process, the composition of the
mixture of substrates, and to avoid inhibition of the
anaerobic digestion process.
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Materials and methods
Characterization of the waste
fermentation broth
The pharmaceutical broth originated from
clavulanic acid production using the mycelium or-
ganism Streptomyces clavulagerus. During its pro-
duction a considerable amount of waste broth
(spent mycelia) is produced, which has to be dis-
posed of with minimum environmental impact.
Characterization of the broth was accomplished us-
ing two different batches of waste broth named
Batch 1 and Batch 2, sampled at three weeks inter-
val. The aim of multiple sampling was to obtain
average values of the measured parameters and
to assess the impact of changes in broth quality
on its treatment characteristics. Until the experi-
ments, waste broth was kept in a cool dark storage
(4 ± 1 °C). Prior to the anaerobic digestion experi-
ments, the waste broth was analyzed and character-
ized in terms of its biodegradability and toxicity. Its
toxicity towards a mixed culture of aerobic micro-
organisms by measurements of the inhibition of
oxygen consumption9 was determined, and Vibrio
fischeri bioluminescence inhibition10 was measured.
In both cases the EC50 values were calculated as the
vol. % of the sample which affects 50 % of the
tested organisms. The biodegradability of the
diluted broth (0.15 vol. %, initial COD was
100 mg L–1) was assessed by measurement of
oxygen consumption in a closed respirometer.11 The
contribution of abiotic elimination was also evalu-
ated.
To compare biodegradability of the broth in
aerobic and anaerobic conditions, two stabilization
studies were carried out to measure changes in tox-
icity during its biodegradation, as well as changes
of other parameters (COD, DOC, NH4+-N, NO2–-N,
Cl–, Etc.) versus time.12 The stabilization study rep-
resented a link between biodegradation and changes
in toxicity of the sample. Stabilization (ageing)
allowed us to assess the toxic fraction as permanent
or biodegradable. At the same time, we could also
differentiate among toxicity originating from raw
wastewater and that formed during degradation
processes as a consequence of stable metabolites.
These studies were performed in a 10 L batch
reactor, where the broth was diluted 14 times
(7 vol. %). In the first experiment, the reactor was
aerated (400 rpm) to maintain more than 6 mg L–1
of O2 (28 days, aerobic conditions), while in the
second, the system was sealed to assure less than
0.1 mg L–1 of O2 (28 days, anaerobic conditions).
Samples were redrawn during both experiments pe-
riodically to determine COD, BOD5, DOC, NH4-N,
NO2–-N, Cl– and toxicity as for the raw broth.
Reactor design and conditions
For digestion experiments, a 30 L pilot plant
anaerobic digester was used under mesophilic
conditions. This reactor was designed to handle
semi-solid substrates with semi-continuous feed of
substrate daily (setup shown in Fig. 1). The temper-
ature of the reactor was set to 37 ± 1°C, to simulate
the conditions of the full-scale device, which is go-
ing to utilize the pharmaceutical broth for biogas
production. The initial experiment was a control
trial, where only pig slurry and corn-grass silage
were used as substrates as in the full-scale rector.
The designed Organic Loading Rate (OLR) was
1.5 kg m–3 d–1. To handle the semi-solid input sub-
strate like corn-grass silage, a part of the reactor
effluent (reflux) was used in order to achieve appro-
priate hydraulic properties for liquid handling of all
substrates in the influent. In the control experiment
is applied 1515 mL (125 mL of pig slurry, 100 g
(250 mL strewed) of corn-grass silage and 1250 mL
of reactor effluent. In further experiments where
pharmaceutical broth was introduced in the influent
of the digestion reactor, the mixture of 50 vol. % of
Batch 1 and 50 vol. % of Batch 2 was used.
In the first experiment with pharmaceutical
waste broth, the addition of pharmaceutical broth
matches the conditions that would occur in the
full-scale model. The OLR was 1.8 kg m–3 d–1.
1465 mL of mixture was used as a feed; a part of
the reactor effluent was substituted with pharma-
ceutical broth (125 mL pig slurry, 100 g of corn-grass
silage, 1000 mL of reactor effluent and 200 mL of
pharmaceutical broth). The second experiment was
planned to gradually increase the amount of phar-
maceutical broth followed by increased organic
load to the point where the anaerobic process would
be inhibited. The amount of pharmaceutical broth
was increased by 50 %, because the organic load
was still relatively low. With the 1565 mL of the
substrate feed (125 mL of pig slurry, 100 g of
486 G. D. ZUPANÈIÈ and A. CGAJNAR GOTVAJN, Anaerobic Treatment of …, Chem. Biochem. Eng. Q. 23 (4) 485–492 (2009)
F i g . 1 – Setup of the digestion reactor
corn-grass silage, 1000 mL of reactor effluent and
300 mL of pharmaceutical broth) the OLR was
raised to 2.2 kg m–3 d–1. Other authors reported
effective biogas production at OLRs larger than
2.2 kg m–3 d–1,3,5,6 while some reports even exceeded
10 kg m–3 d–1;4,8,13 therefore, OLR of 2.2 kg m–3 d–1
was considered low enough not to pose a problem.
After the occurrence of inhibition in the second ex-
periment, the OLR was reduced to 2.0 kg m–3 d–1 by
reducing the amount of pharmaceutical broth in the
entering substrate. 1515 mL of substrate (125 mL of
pig slurry, 100 g of corn-grass silage, 1000 mL of
reactor effluent and 250 mL of pharmaceutical
broth) was introduced into the reactor daily. In the
third experiment, only pharmaceutical broth alone
was used as a substrate (600 mL per daily feed,
OLR was 1.6 kg m–3 d–1).
Analytical methods
Waste broth (Batch 1 and Batch 2) was ana-
lyzed prior to the anaerobic digestion experiments.
Analytical control of the waste broth included pH,
BOD5,14 COD,15 DOC (Shimadzu TOC 5000A An-
alyzer, 1998)16 and nitrogen as ammonium17 and ni-
trate nitrogen18 determination. Chloride was mea-
sured by a titrimetric method.18 The same parame-
ters were also followed during the stabilization
study. In Batch 2, concentrations of AOX,19 met-
als,20,21 PAHs22 and PCB23 were also determined in
accordance with Slovenian legislation for pharma-
ceutical wastewaters.24
During operation of the pilot reactor, the char-
acteristics of the influent and effluent were mea-
sured on a daily basis for COD, total suspended sol-
ids (TSS), volatile suspended solids (VSS) and pH
according to Standard Methods.18 In addition, the
biogas flow was measured online using an Agilent
ADM 2000 device and later its composition was
determined by GC/MS method.
Results and discussion
Characterization of the waste
fermentation broth
Physical-chemical and toxicological analyses
of the raw sample are presented in Table 1. The av-
erage COD of pharmaceutical broth was 75 g L–1
with a high solids content of 60 g L–1; 94 % of sol-
ids were volatile, indicating a large proportion of
organic material that can be usefully transformed to
biogas. BOD5 was in the range of 9–30 g L–1, DOC
reached up to 18.5 g L–1 and the concentration of
NH4-N was 54 to 75 mg L–1. The waste broth did
not contain AOX, BTX or PCB, while concentra-
tions of metals were low, except for Zn, which was
added to the broth at the beginning of the fermenta-
tion process as an essential growth element.
The toxicity and biodegradability of the waste
broth is presented in Table 2 and Table 3. Batch 2
was less toxic to luminescent bacteria and activated
sludge than Batch 1. The mixed culture of aerobic
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T a b l e 1 – Physical-chemical analysis of the waste fermen-
tation broth
Parameter Batch 1 Batch 2
pH 5.4 ± 0.1 6.1 ± 0.1
COD/mg L–1 73000 ± 5000 75900 ± 5000
DOC/mg L–1 18500 ± 370 17900 ± 350
IC/mg L–1 2000 ± 40 30 ± 0.6
BOD5 /mg L









Cl– /mg L–1 600 ± 50 781 ± 50
AOX/g L–1 / < 2500
BTX/g L–1 / < 0.5
PCB/g L–1 / < 5
Total Cr/g L–1 / 44.9
Co/g L–1 / 2.9
Ni/g L–1 / 26.0
Cu/g L–1 / 270
Zn/g L–1 / 7642
Cd/g L–1 / 0.8
Pb/g L–1 / 1.1
As/g L–1 / 2.5
Se/g L–1 / < 10.0
/… Not determined.
T a b l e 2 – Toxicity of the waste fermentation broth




1 30 min EC50 (vol. %) 1.19




1 180 min EC50 (vol. %) 4.11
2 180 min EC50 (vol. %) 15.32
T a b l e 3 – Aerobic biodegradability of diluted waste fer-
mentation broth
Batch Biodegradation/% Abiotic removal/%
1 74 ± 3 9 ± 2
2 66 ± 5 30 ± 7
activated sludge was less sensitive to toxic com-
ponents in the waste broth than the Vibrio fischeri
culture. The toxicity of the broth could not be
correlated with its composition. Diluted broth
(0.15 vol. %, COD = 100 mg L–1) also degraded
readily (66–74 %). In the case of Batch 2, the
abiotic control was not sterilized reliably, so the
high level of abiotic removal (Table 3, 30 %) could
be attributed to the presence of native active and re-
sistant microorganisms in the broth, which were
able to degrade the diluted broth even after steril-
ization by addition of HgCl2 (10 g L–1, as recom-
mended by standard procedure10), because many
bacterial cells were detected by microscopic exami-
nation in the abiotic control after the biodegradation
experiment confirming non-sterile conditions. The
initial toxicity and biodegradability testing con-
firmed that with dilution of the broth its toxicity
could be avoided and its biodegradability in aerobic
conditions could be increased. To determine the
feasibility of anaerobic treatment of such a waste
broth and to assess its performance relative to aero-
bic treatment, stabilization studies in aerobic and
anaerobic conditions were performed.
The results of the aerobic stabilization study
with Batch 1, presented in Fig. 2, indicated 80 %
COD removal and 86 % DOC removal. 88% of
BOD5 was also removed (397/47 mg L–1) in 28 days.
The concentration of NH4-N decreased by 73 %
(351.5/95.5 mg L–1), while the concentration of
NO2–-N remained below 2 mg L–1. The concentra-
tion of chloride increased by 192 % (233/681 mg L–1)
due to the degradation processes. However, the re-
maining degraded broth was much more toxic to
Vibrio fischeri (30 min EC50 = 0.50 vol. %) and ac-
tivated sludge (180 min EC50 = 1.28 vol. %) after
28 days of degradation in aerobic conditions than
the raw waste pharmaceutical fermentation broth
(Table 2). This could be explained by the formation
of toxic and harmful by-products/metabolites dur-
ing aerobic biodegradation. The residue was also
poorly biodegradable according to measurement of
oxygen consumption. Its biodegradability reached
22 ± 3 %, while abiotic elimination was 12 ± 4 %.
On the other hand, degradation of Batch 2 in
anaerobic conditions resulted in a non-toxic resi-
due. COD removal reach 75 % while DOC re-
moved 86 %. These removal rates in anaerobic con-
ditions were identical to those aerobic (Fig. 3), but
degradation started later and was much slower. BOD5
dropped from an initial 2600 mg L–1 to 495 mg L–1
(81 %), while ammonium nitrogen increased by
268 % (68/250 mg L–1) as a result of biodegradation
of organic matter, which was not followed by nitri-
fication. This was also confirmed by an increase in
nitrite N concentration (17.8/39.6 mg L–1). The con-
centration of the chloride went up by 31 %.
Since the anaerobic stabilization study revealed
that the remaining broth was less toxic to Vibrio
fischeri (30 min EC50 = 44.7 vol. %) and activated
sludge (180 min EC50 = 68.9 vol. %) than the raw
broth (Table 2), it was estimated that the majority of
toxic compounds were effectively removed during
anaerobic degradation and probably no toxic me-
tabolites were formed. The residue of anaerobic sta-
bilization was also poorly biodegradable later in
aerobic conditions. It biodegraded less than 5 % in
a closed respirometer, while its abiotic elimination
reached a negligible 2 %.
It was confirmed that anaerobic digestion of
the investigated waste pharmaceutical fermentation
broth has certain advantages. Degradation is slower
than in aerobic conditions, but according to COD,
DOC and BOD5 the degradation levels attained are
comparable. On the other hand, nitrification is sup-
pressed in anaerobic conditions. But the final anaer-
obic residue is stable and less toxic, and thus more
suitable for final disposal. Because stabilization
studies were performed using diluted broth, it was
estimated that further experiments in the mesophilic
anaerobic digester should also be performed with
diluted pharmaceutical broth to avoid toxic shock
and to allow possible adaptation of the biomass.
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F i g . 2 – Concentrations of COD and DOC during the
aerobic stabilization study
F i g . 3 – Concentrations of COD and DOC during anaero-
bic stabilization study
Start-up of the reactor and control experiment
To start up the reactor, 10 L of active anaerobic
sludge (concentration 25 g L–1) from the local sew-
age sludge digestion plant was used as inoculum
(1/3 of the reactor). 125 mL of pig slurry, diluted
with tap water (approx. 450 mL) and 100 g of
corn-grass silage was fed into the reactor on a daily
basis over the next 30 days, until the 30 L volume
were filled. There were no problems regarding
start-up of the reactor. A control experiment was
then conducted over an additional 33 days with pig
slurry and corn-grass silage only, the characteristics
of influent and operation conditions matching the
conditions in the local biogas plant. Average influ-
ent and effluent values are shown in Table 4; pro-
cess efficiency is presented in Fig. 4. With the OLR
of 1.5 kg m–3 d–1 the control experiment showed an
expected COD removal of 70 % and TSS and VSS
degradation of 77 % and 80 %, respectively. After
33 days, the control experiment was just prolonged
into the first experiment with no adaptation period.
The first experiment
In the first experiment, the amount of pharma-
ceutical broth matching the conditions in the design
of the full-scale model of the local biogas plant was
added. The OLR was 1.8 kg m–3 d–1 which repre-
sents 20 % increase in comparison to the control ex-
periment. Although the increased feed started with
no adaptation period, the system displayed no prob-
lems and it was performing very well under the
higher load of pharmaceutical broth (Fig. 5). The ex-
periment was conducted for 52 days and there were
no significant increases in effluent parameters in
comparison to the control experiment (Table 4). This
first experiment has shown that the pharmaceutical
broth can be easily co-digested; the COD removal
even increased; 79 % compared to 70 % in the con-
trol experiment (Fig. 4, Fig. 5), and reached compa-
rable degradation efficiencies according to TSS (80
%) and VSS (83 %). Regarding the obtained results,
it was estimated that the process had not yet reached
its maximum load and performance, therefore an in-
creased amount of pharmaceutical broth was added
to the influent used in the second experiment.
The second experiment
In the second experiment, the initial OLR
was increased to 2.2 kg m–3 d–1, representing a
22 % increase compared to the first experiment
(1.8 kg m–3 d–1) and a 47 % increase compared to
the control experiment. From the experience in the
first experiment and considering the fact that other
authors reported similar or slightly higher OLR
with pharmaceutical wastewaters,3,5,6 no problems
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T a b l e 4 – Average influent and effluent values of all experiments
Influent parameters Effluent parameters
COD/g L–1 TSS/g L–1 VSS/g L–1 pH COD/g L–1 TSS/g L–1 VSS/g L–1 pH
Control experiment 84.7 93.8 86.5 6.6 24.8 21.4 16.7 7.5
First experiment 112.8 109.4 103.1 6.2 24.0 21.7 17.5 7.5
Second experiment 117.4 101.4 95.3 6.0 36.2 26.1 21.7 7.6
Third experiment 82.0 61.6 57.6 5.2 * 21.4 18.0 *
* Due to the occurred inhibition, followed by increase or decrease of value, average values are not representative.
F i g . 4 – Degradation of TSS, VSS and COD removal in the
control experiment
F i g . 5 – Degradation of TSS, VSS and COD removal in the
first experiment
were expected in process performance. For the first
20 days of operation performance was excellent;
average COD removal was 80 %, average TSS and
VSS degradation were 79 % and 82 %, respectively
(Fig. 6). After day 20 the process efficiency started
to deteriorate rapidly. In just 7 days COD removal
decreased to 68 %, pH dropped from 7.6 to 7.2, and
the biogas production decreased by nearly 60 %
(Fig. 8). At this point, we decided to stop feeding
the reactor for 3 days to induce recovery. After
3 days the experiment continued from day 31 to
day 48 using the same influent as in the first experi-
ment (OLR was 1.8 kg m–3 d–1). After day 48, the
amount of pharmaceutical broth was increased to
achieve the OLR of 2.0 kg m–3 d–1. Process perfor-
mance was relatively constant, the pH was again
7.6 and the biogas production increased; however
the average COD reduction was only 70 % whereas
average TSS and VSS degradation were 74 % and
77 % respectively. The most likely reason for such
abrupt process inhibition is a probable toxic effect
originating from the pharmaceutical broth, because
the organic overload at OLR 2.2 kg m–3 d–1 under
these conditions is highly unlikely.3,5,6 To test the
possibility of the inhibitory effect of the pharma-
ceutical broth, we conducted the third experiment
with pharmaceutical broth as a single substrate, re-
sulting in lower ORL.
The third experiment
In the third experiment, only pharmaceutical
broth with OLR of 1.6 kg m–3 d–1 was used as in-
flow substrate. After approx. 130 days of overall
operation with pharmaceutical broth as a co-sub-
strate, and process failure and recovery in the sec-
ond experiment, it was assumed that the contact
time of pharmaceutical broth and mesophilic sludge
was sufficiently long (over 6 retention times) to at-
tain possible adaptation that should enable intro-
duction of pharmaceutical broth as a single sub-
strate.
For a period of 10 days the process ran in the
range of expected parameters (Fig. 7), pH was in the
range of 7.5 to 7.6. In the next 15 days, pH remained
between 7.4 and 7.5. During the first 25 days of the
third experiment, average COD removal was 57 %,
with no trend of decreasing. After day 25, COD re-
moval started to decrease and after 20 days the pro-
cess failed completely. The pH also decreased gradu-
ally from 7.4 on day 25 to 6.9 on day 46. Obviously,
the waste pharmaceutical broth had a toxic effect on
the anaerobic digestion, because the applied OLR of
1.6 kg m–3 d–1 was sufficiently low to exclude an or-
ganic overload. On the other hand, VSS and TSS re-
moval showed no decrease during the process failure
(Fig. 7). The average TSS and VSS removal was
65 % and 68 %, respectively. That could be ex-
plained with good performance of hydrolysis stage
of anaerobic process which remained unaffected by
the toxic impact of the waste broth.
Biogas production
Biogas production in the control experiment re-
garding methane was 25.4 L d–1, specific methane
production (SMP) was 646 L kg–1 of COD and
633 L kg–1 of VSS inserted. The biogas consisted in
average of 65 % methane and 35 % of CO2.
In the first experiment, methane production
reached 30.9 L d–1, which represents a 21 % in-
crease according to 20 % increase of OLR. SMP
was 590 L kg–1 of COD and 645 L kg–1 of VSS in-
serted, which is comparable to the production in the
control experiment. The average composition of biogas
was 70 % methane and 30 % CO2. At the beginning
of the second experiment, methane production was
about 35 L d–1 (Fig. 8), with SMP 537 L kg–1 of
COD and 628 L kg–1 of VSS inserted, before the
process started to collapse. When the feeding of the
reactor was stopped in order to induce recovery (in
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F i g . 6 – Degradation of TSS, VSS and COD removal in the
second experiment
F i g . 7 – Degradation of TSS, VSS and COD removal in the
third experiment
the second experiment), the methane production
was only 8-10 L d–1, with low SMP of 283 L kg–1 of
COD and 356 L kg–1 of VSS inserted. After recov-
ery of the system, the average methane production
increased to 29.4 L d–1 with average SMP of
475 L kg–1 of COD and 585 L kg–1 of VSS inserted.
Volume % of methane during the second experi-
ment is shown in Fig. 8.
In the first 10 days of the third experiment av-
erage methane production was 22.5 L d–1 (Fig. 9).
That was in the range of expected value, due to
lower OLR in the third experiment. Average SMP
was 484 L kg–1 of COD and 654 L kg–1 of VSS in-
serted, which is comparable to all other experi-
ments. Average methane content in biogas was
56.3 % which is lower than in other experiments.
After day 10, a rapid deterioration of the process
efficiency began. Methane production declined to
2.6 L d–1, the process was subsequently totally in-
hibited and stopped.
Conclusions
This study has demonstrated that anaerobic di-
gestion of waste pharmaceutical broth as a single
substrate is not possible due to toxic effect. How-
ever, anaerobic co-digestion of pig slurry, corn-grass
silage and pharmaceutical broth with beneficial ef-
fects is possible. Our conclusion is that the co-di-
gestion in full scale will proceed with no adverse
effects providing two conditions are met. Firstly,
the OLR of 2.0 kg m–3 d–1 must not be exceeded for
longer periods of time (more than 7 days), and sec-
ondly, the pharmaceutical broth must not constitute
more than 25 % of total OLR, to avoid toxic effects.
It has been shown, that under strictly defined condi-
tions it is possible to avoid the toxic effects of phar-
maceutical waste broth on anaerobic biomass and
conduct co-digestion successfully.
L i s t o f s y m b o l s
AOX  Absorbable Organic Halogens
BOD5  Biochemical Oxygen Demand, mg L
–1
BPR  Biogas Production Rate, m3 of biogas per m3
of reactor per day, m3 m–3 d–1
BTX  Benzene, Toluene, Xylene
COD  Chemical Oxygen Demand, mg L–1
DOC  Dissolved Organic Carbon, mg L–1
HRT  Hydraulic Retention Time, days
NH4-N Ammonium Nitrogen, mg L
–1
OLR  Organic Loading Rate of COD, kg of COD per
m3 of reactor per day, kg m–3 d–1
PAH  Polycyclic Aromatic Hydrocarbons
PCB  Polychlorinated Biphenyls
SMP  Specific Methane Productivity, m3 of methane
per kg of COD/VSS inserted, m3 kg–1
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